ID   AHM-3D3
AC   CVCL_B0P5
DR   Wikidata; Q108819836
RX   Patent=EP0124301A1;
CC   Group: Hybridoma fusion partner cell line.
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); CRL-8221.
CC   Selected for resistance to: ChEBI; CHEBI:9555; Tioguanine (6-thioguanine; 6-TG).
CC   Transformant: ChEBI; CHEBI:23994; Ethyl methanesulfonate (Methylsulfonic acid ethyl ester; MSEE).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3242; Plasma cell myeloma
DI   ORDO; Orphanet_29073; Multiple myeloma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_B0P4 ! AHM-1
SX   Male
AG   64Y
CA   Cancer cell line
DT   Created: 23-09-21; Last updated: 29-06-23; Version: 4
//
RX   Patent=EP0124301A1;
RA   Chen P.M.-C.J., Luderer A.A., Harvey M.A.;
RT   "Human hybrid cell lines, production and use thereof.";
RL   Patent number EP0124301A1, 07-Nov-1984.
//